An outstanding management team composed of high-level talents with overseas pharmaceutical R&D background and extensive commercialization experience.
-
Management Team -
Honors CourseUtidelone has been selected twice for oral presentations at the ASCO annual meeting and approved in 2021 for the treatment of mBC.
-
Product PipelineBuilding balanced and differentiated pipeline covering products from early- to late-stage through both in-house development and in-licensing.